OMEGA HEALTHCARE INVESTORS INC

Listed Company

OHICIK 0000888491NYSELarge AcceleratedReal Estate Investment TrustsMarylandFY ends Dec 31

Period

FY 2025

Revenue

$1.19B

Net Income

$590.18M

Total Assets

$10.05B

Equity

$5.18B

Shares Out

297.80M

Op. Cash Flow

$878.55M

OHI$50.21+32.83% · past yearDBEQ Basic

Daily closing prices

Business

Omega Healthcare Investors, Inc. is a real estate investment trust that owns and finances healthcare-related properties in the United States, United Kingdom, and Canada, primarily skilled nursing facilities, assisted living facilities, independent living facilities, specialty facilities, and continuing care retirement communities. The company generates revenue through triple-net operating leases with third-party healthcare operators, real estate mortgage loans, and a recently initiated RIDEA (managed) structure for selective facilities. Omega's portfolio comprises 1,027 consolidated operating healthcare facilities operated by 89 third-party operators or managers across 42 U.S. states, Washington D.C., the United Kingdom, and Bailiwick of Jersey.

Summary from 10-K filed 2026-02-09

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Rental income	1,002	888	826	751	—
Interest income	175	157	120	124	136
Miscellaneous income	13	6	3	3	2
Total revenues	1,190	1,051	950	878	1,063
Depreciation and amortization	325	305	320	332	342
General and administrative	104	88	82	69	65
Real estate taxes	14	15	15	16	12
Acquisition, merger and transition related costs	4	12	5	42	2
Impairment on real estate properties	23	24	92	38	45
Provision (recovery) for credit losses	2	−15	45	69	78
Interest expense	215	222	236	233	235
Total expenses	688	649	794	800	777
Other income - net	50	7	20	−2	−581,000
Gain (loss) on debt extinguishment	5	−2	−492,000	−389,000	−31
Gain on assets sold - net	67	13	80	360	162
Total other income	122	18	99	358	130
Income before income tax expense and income from unconsolidated entities	624	421	256	436	416
Income tax expense	−15	−11	−6	−5	−4
(Loss) income from unconsolidated entities	−218,000	8	−582,000	7	16
Net income	609	418	249	439	428
Net income attributable to noncontrolling interest	−19	−11	−7	−12	−12
Net income available to common stockholders	590	406	242	—	—
Net income available to common stockholders (per share)	1.96	1.57	1.01	1.81	1.76
Net income available to common stockholders (per share)	1.94	1.55	1	1.8	1.75

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Buildings and improvements	7,902	7,342	6,894	7,348	7,516
Land	1,179	997	870	924	919
Furniture and equipment	540	510	470	500	520
Construction in progress	12	211	138	89	74
Total real estate assets	9,633	9,060	8,372	8,860	9,029
Less accumulated depreciation	−2,931	−2,721	−2,470	−2,323	−2,182
Real estate assets - net	6,703	6,339	5,903	6,537	6,847
Investments in direct financing leases - net	—	9	9	9	—
Real estate loans receivable - net	1,381	1,428	1,212	1,043	—
Investments in unconsolidated entities	414	89	188	179	195
Assets held for sale	4	56	67	9	203
Total real estate investments	8,502	7,922	7,379	7,777	8,437
Non-real estate loans receivable - net	330	332	276	225	124
Total investments	8,832	8,254	7,655	8,002	8,561
Cash and cash equivalents	27	518	443	297	21
Restricted cash	28	30	2	4	4
Contractual receivables - net	10	13	12	8	11
Other receivables and lease inducements	279	249	215	178	252
Goodwill	645	644	644	643	651
Other assets	229	189	148	273	139
Total assets	10,049	9,898	9,117	9,405	9,638
Revolving credit facility	242	—	20	19	—
Secured borrowings	—	243	62	367	362
Senior notes and other unsecured borrowings - net	4,014	4,596	4,985	4,901	4,891
Accrued expenses and other liabilities	353	328	288	315	277
Total liabilities	4,609	5,167	5,355	5,602	5,530
Preferred stock $1.00 par value authorized - 20,000 shares, issued and outstanding - none	—	—	—	—	—
Common stock $0.10 par value authorized - 700,000 shares, issued and outstanding - 295,539 shares as of December 31, 2025 and 279,129 shares as of December 31, 2024	30	28	25	23	24
Additional paid-in capital	8,693	7,916	6,671	6,314	6,428
Cumulative net earnings	4,677	4,087	3,681	3,438	3,011
Cumulative dividends paid	−8,297	−7,517	−6,831	−6,187	−5,554
Accumulated other comprehensive income	79	23	29	20	−2
Total stockholders' equity	5,181	4,537	3,575	3,609	3,907
Noncontrolling interest	259	194	188	194	201
Total equity	5,440	4,731	3,762	3,803	4,108
Total liabilities and equity	10,049	9,898	9,117	9,405	9,638

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Straight-line rent and other write-offs	28	4	21	—	—
Amortization of deferred financing costs and loss on debt extinguishment	968,000	12	14	13	43
Stock-based compensation expense	44	37	35	27	21
Straight-line rent and effective interest receivables	−50	−43	−42	−59	−51
Interest paid-in-kind	−14	−11	−11	−9	−7
Loss from unconsolidated entities	6	2	182,000	455,000	−2
Other non-cash items	−26	−2	−9	—	—
Contractual receivables	3	−845,000	−4	3	−23
Lease inducements	−9	−61,000	−15	6	−14
Other operating assets and liabilities	3	34	4	6	−5
Net cash provided by operating activities	879	749	618	626	722
Acquisition of real estate	−683	−409	−262	−230	−616
Net proceeds from sale of real estate investments	283	95	585	759	319
Investments in construction in progress	−34	−69	−44	−17	−95
Investment in loan receivables and other	−174	−470	−421	−372	−251
Collection of loan principal	247	208	165	346	156
Investments in unconsolidated entities	−122	−971,000	−12	−113,000	−10
Distributions from unconsolidated entities in excess of earnings	13	1	9	3	18
Capital improvements to real estate investments	−81	−38	−38	−47	−45
Proceeds from foreign currency forward contracts	4	8	11	—	—
Receipts from insurance proceeds	7	3	7	1	6
Net cash used in investing activities	−540	−671	−770,000	443	−524
Proceeds from long-term borrowings	1,312	658	507	597	2,275
Payments of long-term borrowings	−1,897	−1,145	−735	−589	−2,178
Payments of financing related costs	−27	−7	−4	−389,000	−49
Net proceeds from issuance of common stock	607	1,236	336	8	—
Dividends paid	−780	−685	−644	−633	−638
Net payments to noncontrolling members of consolidated joint venture	—	545,000	−202,000	81,000	—
(Payments for) proceeds from derivative instruments	−2	—	93	—	—
Redemption of Omega OP Units	−6	−684,000	−77,000	−10	−79,000
Distributions to Omega OP Unit Holders	−44	−29	−26	−20	−25
Net cash (used in) provided by financing activities	−838	26	−473	−789	−341
Effect of foreign currency translation on cash, cash equivalents and restricted cash	5	−580,000	430,000	−3	7,000
(Decrease) increase in cash, cash equivalents and restricted cash	−494	104	144	276	−143

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is OMEGA HEALTHCARE INVESTORS INC's CIK number?

OMEGA HEALTHCARE INVESTORS INC's SEC CIK number is 0000888491 (888491). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find OMEGA HEALTHCARE INVESTORS INC's SEC filings?

All of OMEGA HEALTHCARE INVESTORS INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did OMEGA HEALTHCARE INVESTORS INC last report earnings?

OMEGA HEALTHCARE INVESTORS INC (OHI) most recently filed an earnings 8-K with the SEC on Apr 28, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000888491-26-000016). This is OMEGA HEALTHCARE INVESTORS INC's most recent earnings filing of record — not a forecast of its next earnings date.

What is OMEGA HEALTHCARE INVESTORS INC's most recent earnings 8-K?

OMEGA HEALTHCARE INVESTORS INC's latest earnings 8-K (Item 2.02) was filed Apr 28, 2026 under accession 0000888491-26-000016. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View OMEGA HEALTHCARE INVESTORS INC's latest earnings 8-K →
Look up any company's CIK number →